WellPoint's Reuters Response PR Newswire (press release)
22.04.10
/PRNewswire-FirstCall/ -- Today, WellPoint, Inc. (NYSE: WLP ) issued the following points of clarification in response to the Reuters article published this morning.
Today's Reuters story alleging that WellPoint employs a targeted rescission policy for members with breast cancer is inaccurate and grossly misleading . The story incorrectly reports that WellPoint singles out women with breast cancer for aggressive investigation with the intent of canceling their insurance. This is simply wrong. In fact, WellPoint works to prevent breast cancer, to detect it early, and to get our members into treatment. We also work to ensure that all of our members are getting best practice care for breast cancer.
The story also misstates the role of what it terms computer algorithms . Contrary to how its use was portrayed in the story, such software is used to look at a series of diagnostic codes meant to capture conditions that applicants would likely
Source: